Skip to content

Topics: Medical research

  • MS patients with higher B cell counts have a better vaccine response

    MS patients treated with Rituximab have better responses to the COVID-19 vaccine if they have higher B cell counts. This is the finding of a study from Uppsala University published in the journal JAMA Network Open. In patients with B cell counts of 40/µL (microlitres) or more, 9 of 10 patients developed protective levels of antibodies, while significantly fewer with lower counts had similar respon

  • Acute sleep loss may alter the way we see others

    A new study from Uppsala University shows that young adults when sleep-deprived evaluate angry faces as less trustworthy and healthy-looking. Furthermore, neutral and fearful faces appear less attractive following sleep loss. The findings are published in the scientific journal Nature and Science of Sleep.

  • Subgroups of glioblastoma associated with disease prognosis

    Researchers at Uppsala University have detected different subgroups of the brain tumour form glioblastoma, where the cancer cells’ properties depend on which cell type they originate from. The used analysis method could also separate glioblastoma patients with significant differences in survival. The findings open up for identifying specific therapeutic targets for the new subgroups of glioblastom

  • Symptom data help predict COVID-19 admissions

    In COVID Symptom Study Sweden more than 10 million daily reports from participants in COVID Symptom Study Sweden from April 2020 to February 2021. The scope of the study was to develop and evaluate a framework to estimate the regional prevalence of COVID-19 using symptom-based surveillance, and to test if these prevalence estimates could be used to predict subsequent trends in COVID-19 admissions.

  • Ancestors of legionella bacteria infected cells two billion years ago

    Researchers at Uppsala University have discovered that the ancestors of legionella bacteria infected eukaryotic cells as early as two billion years ago. It happened soon after eukaryotes began to feed on bacteria. These results, described in a new study published in Molecular Biology and Evolution, also contributes to the chicken-or-egg debate about whether mitochondria or phagocytosis came first

  • Promising molecule for treatment of COVID-19

    Uppsala researchers have succeeded in designing a molecule that inhibits the replication of coronaviruses and that has great potential for development into a drug suitable for treating COVID-19. The molecule is effective against both the new variant and previously identified coronaviruses. The article has been published in the Journal of the American Chemical Society.

  • Unequal knowledge about cardiovascular diseases

    Although many people know what increases the risk of cardiovascular diseases, such as heart attacks, not everyone recognises their own risk factors. This is shown by a new study of 423 Swedes aged 40–70 years, which has now been published in the scientific journal Preventive Medicine Reports.

  • Zebrafish and AI replace some mouse experiments in cancer research

    Researchers at Uppsala University have used AI to develop a new method to study brain cancer. The method is based on transplanting tumour cells from patients to fish embryos, followed by observation with AI. The method, which is described in the scientific journal Neuro-Oncology, can partly replace current mouse models for studying tumour growth and treatment.

  • Hunt for the protein TGM1 led to disease discovery

    Searching for the protein TGM1 among patients with autoimmune skin diseases, researchers have identified a separate disease that can be linked to autoimmunity against TGM1. This backward method demonstrates a new way of identifying autoantigens as markers for serious diseases. By letting autoantigens point to the disease, diagnosis and treatment can be facilitated, shows study published in PNAS.

  • Blocking inhibits SARS-CoV-2 infection of human cells

    Researchers have developed and used a new method to map interactions on a large scale between human proteins and coronavirus proteins, which has provided valuable new information. In collaborations with others, they show that blocking one of these interactions inhibited infection of human cells by SARS-CoV-2. They also confirmed the interaction between the viral protein and the human protein.

  • Expectations and dopamine can affect outcome of SSRI treatment

    Levels of dopamine and placebo effect can determine whether social anxieties improve when treated with SSRIs. The effect was four times higher for patients with high expectations compared with low expectations, even though the groups received the same medical treatment. Although SSRIs influence levels of serotonin in the brain, the effects on dopamine had the greatest impact for improvement.

  • How do probiotic bacteria benefit the intestine?

    Interaction between the gut microbiota and the immune system is important for host physiology and susceptibility to disease, but also for the efficacy of e.g., cancer immunotherapies. A multidisciplinary research team have now discovered that specific probiotic bacteria shape the intestinal microbiome by affecting B lymphocytes in the Peyer’s patches to induce, produce and release IgA following t

  • More effective treatment of Alzheimer’s

    Researchers at Uppsala University have designed new antibodies that might provide more effective treatment methods for Alzheimer’s disease. By designing antibodies that bind even to the smaller aggregates, or clumps, of the amyloid-beta protein, it may be possible to check the progress of the disease. The results presents in Translational Neurodegeneration.

  • Allergic stimulation activates mast cell precursor cells

    Mast cell precursor cells do not just cause an increase in mature mast cells during inflammation, they also play an active role in diseases like asthma. This finding is in a new study by immunology researchers published in the Journal of Allergy and Clinical Immunology. The study also emphasises that precursor cells in general can play an active role in inflammation and challenges the current ide

  • New method used to study how cancer cells are organised

    Changes in individual cancer cells over time may explain why brain tumours develop so differently, and why some cancer cells are resistant to certain treatments. To track the development of cancer cells, researchers at Uppsala University have devised a new method that, in the long term, may make it easier to develop new, effective drug combinations.

  • ​Genetic test better than blood test for cardiovascular diseases

    Determining an individual’s blood group based on genetic tests instead of merely traditional blood tests can provide a better picture of the risk of cardiovascular diseases. If a patient has two genetic variants of A, B or AB, the risk is twice as high compared with if one is O. This is the finding of a new study from the Uppsala University using data from UK Biobank.

  • History of human antibiotic use written in the oral bacteria of wild brown bears

    An international team of researchers used historical museum collections to study the effects of human-made antibiotics over the entire history of their application. They found that the increased use of antibiotics in medicine and agriculture in the 1950-1990s led to increases in antibiotic resistance in wild Swedish brown bears. However, the latest 20 years show a downward trend in resistance.

  • How hormones may alleviate side-specific movement difficulties after brain injury

    Hormones released after a brain injury contribute to movement problems on the left and right sides of the body, scientists from Uppsala University and elsewhere can now show in a new study in rats. The results also suggest that hormone-blocking treatments may help counteract these effects, a finding that has implications for treating people with traumatic brain injuries or stroke.

  • Method for discovery of antiviral drugs

    The current COVID-19 pandemic has highlighted the need for methods to identify new or repurposed drugs as antivirals. Researchers at Uppsala University and Karolinska Institutet are now presenting a new screening approach that focuses on the identification of virus-specific morphological changes in virus-infected cells.

Show more